Aller au contenu principal
Profil bibliographique

Katrina M. Nolan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

30Publications signalées
711Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Pneumonia and Respiratory InfectionsRespiratory viral infections researchHIV Research and TreatmentHIV/AIDS drug development and treatmentBacterial Infections and Vaccines

Les publications récentes

Accès ouvert 2025 article OpenAlex

2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A – Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B – Regulatory Agencies’ Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV))

Sarah Hersey, Kristina McGuire, Olga Kholmanskikh, Nicoletta Bivi et autres

The 19th Workshop on Recent Issues in Bioanalysis (19th WRIB) took place in New Orleans, LA, USA on April 7-11, 2025. Over 1200 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest …

de, us, be, ca, fr, nl, at, il, br, cz, Égypte, jp, ch, kr, se (code pays fourni par la source)

3 citations Bioanalysis
Accès ouvert 2025 article OpenAlex

Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine V116

Jianing Li, Heather Loryn Platt, Wen‐Yu Hu, Weifeng Xu et autres

Pneumococcal conjugate vaccines (PCVs) are designed to induce serotype-specific antibodies; however, antibodies raised against pneumococcal polysaccharides in the vaccine can also cross-react to other serotypes based on structural similarities. Cross-reactivity has been demonstrated for some licensed PCVs and is a worthy consideration …

us (code pays fourni par la source)

5 citations Communications Medicine
2025 article OpenAlex

Low Intrinsic Killing Activity and no Impact of Its Positivity on Phase 3 Pneumococcal Vaccine Adult Studies

Weifeng Xu, Joseph M. Antonello, Jennifer L. Nguyen, Chaoyang Ma et autres

BACKGROUND: The opsonophagocytic assay (OPA) is the gold standard for measuring functional antibody responses to bacterial vaccines. However, antibody-independent bactericidal activities, such as those by antibiotics, could contribute to the killing and thus inflate the measured antibody titer. Because of this, an …

us, il (code pays fourni par la source)

0 citations The Journal of Infectious Diseases
Accès ouvert 2025 article OpenAlex

The impact of pneumococcal vaccination and nasopharyngeal colonization on the performance of a serotype-specific urine antigen detection (SSUAD) assay

Kyeongmi Cheon, Ulrike Kirsten Buchwald, Laura L. Hammitt, Jason J. LeBlanc et autres

To better inform pneumococcal immunization policies, ongoing surveillance for pneumococcal community-acquired pneumonia (CAP) is crucial. To estimate the serotype-specific CAP burden of pneumococcal disease following the introduction of a new 15-valent pneumococcal conjugate vaccine (PCV), V114, a 15-plex serotype-specific urine antigen detection …

us, ca (code pays fourni par la source)

2 citations Vaccine
Accès ouvert 2025 article OpenAlex

2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A – Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)

Omar Tounekti, Sandra Prior, Sarah Wassmer, Joshua Xu et autres

The 18th Workshop on Recent Issues in Bioanalysis (18th WRIB) took place in San Antonio, TX, USA on May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest …

ca, us, ch, gb, be, jp, at, au, in, de, br, hu, it, mx, cn (code pays fourni par la source)

11 citations Bioanalysis
Accès ouvert 2025 article OpenAlex

Establishing a new human pneumococcal standard reference serum, MPRSS-01

Joseph M. Antonello, Rocio D. Murphy, Chitrananda Abeygunawardana, Juliana C. Malinverni et autres

ABSTRACT Measuring the immunogenicity of pneumococcal vaccines involves the use of immunoassays to measure serotype-specific immunoglobulin G (IgG) antibody levels post-vaccination with the current Streptococcus pneumoniae human reference serum standard (007sp) for anti-pneumococcal capsule antibodies. Development of new pneumococcal conjugate vaccines (PCVs) …

us, il (code pays fourni par la source)

1 citation mSphere
Accès ouvert 2024 article OpenAlex

Harmonization of Vaccine Ligand Binding Assays Validation

Francis J. Dessy, Ivo Sonderegger, Leslie Wagner, Alessandra Buoninfante et autres

The urgency and importance of organizing a global effort to harmonize clinical assay validation specific to the vaccine industry was identified during the drafting of the 2020 White Paper in Bioanalysis due to the lack of clarity and regulatory guidance/guidelines in vaccine …

be, ch, us, br, nl, no (code pays fourni par la source)

10 citations Bioanalysis
Accès ouvert 2024 article OpenAlex

2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard (Part 3 – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Biotherapeutics Immunogenicity & Risk Assessment; ADA/NAb Assay/Reporting Harmonization)

Johanna R. Mora, Rachel Palmer, Leslie Wagner, Bonnie Wu et autres

The 17th Workshop on Recent Issues in Bioanalysis (17th WRIB) took place in Orlando, FL, USA on June 19–23, 2023. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest in …

de, us, ch, fr, gb, br, at, jp, ca, Égypte, be, nl (code pays fourni par la source)

21 citations Bioanalysis
Accès ouvert 2023 article OpenAlex

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Yaru Shi, Katrina M. Nolan, Robert L. Burton, Tulin Shekar et autres

Pneumococcal serogroups consist of structurally related serotypes, and serotype-specific antibodies can cross-react against other serotypes within the same serogroup. Cross-reactivity of vaccine-induced serotype 6A antibodies, and, to a lesser extent, serotype 6B antibodies, to serotype 6C has been demonstrated following receipt of …

us, de (code pays fourni par la source)

9 citations Human Vaccines & Immunotherapeutics
Accès ouvert 2023 article OpenAlex

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

Katrina M. Nolan, Brent L. Seaton, Joseph M. Antonello, Yuhua Zhang et autres

Assay modernization is a key aspect of vaccine life cycle management. Thus, new, reoptimized versions of two 9vHPV immunoassays have been developed and validated for use in ongoing and future HPV vaccine clinical trials. These assays are suitable for use in high-throughput …

us (code pays fourni par la source)

9 citations mSphere
Accès ouvert 2023 article OpenAlex

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Yaru Shi, Katrina M. Nolan, Robert L. Burton, Rocio D. Murphy et autres

Abstract Background Pneumococcal serotype 6C has structural similarity with serotype 6A and, to a lesser degree, serotype 6B. The 13-valent PCV (PCV13), which contains serotypes 6A and 6B, induces cross-reactive opsonophagocytic killing activity (OPA) antibodies to serotype 6C, with an observed decline …

us (code pays fourni par la source)

0 citations JAC-Antimicrobial Resistance
Accès ouvert 2022 article OpenAlex

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine

Gowrisankar Rajam, Yuhua Zhang, Joseph M. Antonello, Rebecca J. Grant-Klein et autres

Streptococcus pneumoniae has more than 90 serotypes capable of causing a range of disease manifestations, including otitis media, pneumonia, and invasive diseases, such as bacteremia or meningitis. Only a minority (<10%) of pneumococcal diseases are bacteremic with known serotype distribution. Culture and …

us, de (code pays fourni par la source)

18 citations mSphere

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.